Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06564727

Enrollment

Registered

2024-08-21

Start date

2017-01-01

Completion date

2020-01-30

Last updated

2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Aspergillosis, Surgery-Complications, Thoracic Diseases

Brief summary

The objective of this study was to report our experience with U-VATS resection and to evaluate our surgical outcomes with an analysis of postoperative complications. The investigators also estimate the prognostic factors that influence the morbidity and the conversion.

Detailed description

Evaluation of prognostic factors Tuberculosis Hemoptysis Type of aspergilloma presence of complete adherence Procedure

Interventions

PROCEDUREUniportal VATS approach

Uniportal VATS resection for simple pulmonary aspergilloma

PROCEDUREVATS approach

VATS resection for complex pulmonary aspergilloma

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Investigator)

Intervention model description

study the effect of a treatment and evaluate outcome postoperatively

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

\- Treatment using uniportal VATS

Exclusion criteria

\- Resection using thoracotomy

Design outcomes

Primary

Measure	Time frame	Description
postoperative complications	30 days	evaluate the complication at 30 days

Countries

Morocco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026